Indeed, its endogenous expression is inversely correlated with NANOG and OCT4, and its ectopic expression in glioma stem cells is sufficient to repress OCT4 and NANOG, as well as tumor aggressiveness [39]. The gene discussed is POU5F1; the disease is central nervous system cancer.